CHIRON CAPITAL MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHIRON CAPITAL MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$235,980
+29.7%
9,500
-21.5%
0.19%
+47.2%
Q1 2023$181,984
+44.9%
12,100
+14.0%
0.13%
+46.0%
Q4 2022$125,599
+173.0%
10,617
-0.9%
0.09%
+200.0%
Q2 2022$46,000
-64.6%
10,717
-21.7%
0.03%
-64.6%
Q1 2022$130,000
-42.0%
13,692
+16.3%
0.08%
-49.4%
Q4 2021$224,000
+89.8%
11,772
+166.0%
0.16%
+70.5%
Q3 2020$118,0004,4250.10%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders